This is a preview of subscription content, log in via an institution to check access.
References
Mullani NA, Goldstein RA, Gould KL, Marani SK, Fisher DJ, O’Brien HA, et al. Myocardial perfusion with rubidium-82. I. Measurement of extraction fraction and flow with external detectors. J Nucl Med 1983;24:898–906.
Goldstein RA, Mullani NA, Marani SK, Fisher DJ, Gould KL, O’Brien HA Jr. Myocardial perfusion with rubidium-82. II. Effects of metabolic and pharmacologic interventions. J Nucl Med 1983; 24:907–15.
Wilson RA, Shea M, Landsheere CD, Deanfield J, LammertsmaAA, Jones T, et al. Rubidium-82 myocardial uptake and extraction after transient ischemia: PET characteristics. J Comput Assist Tomogr 1987;11:60–6.
Huang SC, Williams BA, Krivokapich J, Araujo L, Phelps ME, Schelbert HR. Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. Am J Physiol 1989;256: H1156–64.
Dahlberg ST, Meerdink DJ, Gilmore MP, Leppo JA. Myocardial extraction of technetium-99m-[2-(1-methoxybutyl) isonitrile] in the isolated rabbit heart: a myocardial perfusion agent with high extraction and stable retention. J Nucl Med 1993;34:927–31.
Ayalew A, Marie PY, Menu P, Mertes PM, Hassan N, Danchin N, et al. A comparison of the overall first-pass kinetics of thallium- 201 and technetium-99m MIBI in normoxic and low-flow ischaemic myocardium. Eur J Nucl Med 2000;27:1632–40.
Wei K, Le E, Bin JP, Coggins M, Jayawera AR, Kaul S.Mechanism of reversible (99m)Tc-sestamibi perfusion defects during pharmacologically induced vasodilatation. Am J Physiol Heart Circ Physiol 2001;280:H1896–904.
Bateman TM, Heller GV, McGhie AL, Friedman JD, Case JA, Bryngelson JR, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol 2006;13:24–33.
Gould KL, Nakagawa Y, Nakagawa N, Sdringola S, Hess MJ, Haynie M, et al. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base to apex, myocardial perfusion abnormalities by non-invasive positron emission tomography. Circulation 2000;101:1931–9.
Nakagawa Y, Nakagawa K, Sdringola S, Mullani N, Gould KL. A precise, three-dimensional atlas of myocardial perfusion correlation with coronary arteriographic anatomy. J Nucl Cardiol 2001; 8:580–90.
Sdringola S, Patel D, Gould KL. High prevalence of myocardial perfusion abnormalities by positron emission tomography in asymptomatic people having a parent or sibling with coronary artery disease. Circulation 2001;103:496–501.
Johnson NP, Gould KL. Clinical assessment of a new concept: resting myocardial perfusion heterogeneity quantified by Markovian analysis of PET identifies coronary endothelial dysfunction and early atherosclerosis in 1034 subjects. J Nucl Med 2005;46: 1427–37.
Sdringola S, Nakagawa K, Nakagawa Y, Yusuf SW, Boccalandro F, Mullani N, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared to usual care cholesterol lowering drugs in coronary artery disease. J Am Coll Cardiol 2003; 41:263–72.
Sdringola S, Boccalandro F, Loghin C, Gould KL. Mechanisms of progression regression of coronary disease by positron emission tomography in relation to treatment intensity and risk of clinical events over 5 year follow-up. J Nucl Med 2006;47:59–67.
Gould KL. Assessing progression or regression of CAD: the role of perfusion imaging. J Nucl Cardiol 2006;12:625–38.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bateman, T.M., Heller, G.V. & James Cullom, S. Reply. J Nucl Cardiol 13, 591–592 (2006). https://doi.org/10.1016/j.nuclcard.2006.05.016
Issue Date:
DOI: https://doi.org/10.1016/j.nuclcard.2006.05.016